Olympus has gained 510(k) clearance from the US Food and Drug Administration (FDA) for its Articulating HD 3D laparoscopic surgical video system.
The system, ENDOEYE FLEX 3D, when compared with conventional 2D surgical systems reduces surgical errors and improves the speed, accuracy and precision of surgical events.
The device's modular design allows clinicians to add an existing Olympus EVIS EXERA III Universal Imaging System, thus helping in reducing the investment necessary to add 3D capability, according to the company.
The device also restores natural 3D vision and depth perception during performing laparoscopic procedures.
Olympus medical systems group president Luke Calcraft said the Olympus HD 3D System brings value to those surgeons that need the precision, resolution, and depth perception of 3D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology.
"We are leading the way with innovations to help our customers realize the clinical efficacy and cost effectiveness required under Accountable Care," Calcraft added.
